Email Post: IMPS-40 ENHANCED VERSIONS OF THE ANTI-EGFRvIII VACCINE REVEAL A POTENTIAL NEW PARADIGM FOR ANTIGEN RECOGNITION AND VACCINE OPTIMIZATION